Rheumatoid arthritis VS psoriatic arthritis: Clinical and US assessment of the wrist and hand jointsEl Miedany, YYoussef, SPalmer, D
Autoimmune diseases psoriatic arthritis and RA have different symptoms, causes, and treatments. Learn how to explain psoriatic arthritis vs rheumatoid arthritis here.
Psoriatic arthritis is a type of inflammatory arthritis that affects as many as 30% of people with psoriasis - a common skin condition.
A less documented entity of psoriatic arthritis was studied in 238 cases of psoriasis and it was detected in 5.1% of cases. The prevalence of arthritis was found in the population over 40 years of age and was 2.7% of the males and 8.2% of the females. Psoriatic arthritis was much more ...
Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G, et al. Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients depend on autoantibody positivity. Ann Rheum Dis 2014;73:2022-8.Kocijan R, Finzel S, Englbreeht M, et al. Differences in ...
Psoriatic arthritis was less frequent in African-Americans compared to Caucasians (30 vs. 64.5%, respectively, p <0.001); however, African-Americans had more severe skin involvement [Psoriasis Area and Severity Index 8.4 (10.0) vs. Caucasians 5.5 (6.4), p =0.06], with greater psychological ...
A psoriatic arthritis diet is important for reducing inflammation and keep your weight down. Learn here.
P Nigam,D Singh,VS Matreja,HN Saxena 摘要: A less documented entity of psoriatic arthritis was studied in 238 cases of psoriasis and it was detected in 5.1% of cases. The prevalence of arthritis was found in the population over 40 years of age and was 2.7% of the males and 8.2% of...
Objectives To determine in a retrospective cohort whether patients with psoriatic arthritis (PsA) who would not have fulfilled the inclusion criteria for randomised controlled trials (RCTs) for the TNF inhibitor (TNFi) chosen for their treatment (excl) have similar benefits and drug survival as thos...
San Francisco—A host of novel medications that have been developed with recombinant DNA techniques are offering physicians new options for treating psoriasis and psoriatic arthritis that cannot be well controlled by standard therapies. An estimated 30% of the 5.5 million people of all ages with psor...